Growth, immune responses and intestinal morphology of rainbow trout (Oncorhynchus mykiss) supplemented with commercial probiotics

The influence of two commercial probiotics on the growth, innate immune parameters and intestinal morphology of rainbow trout (Oncorhynchus mykiss) juveniles (initial weight: 16.4 +/- 0.4 g) was evaluated. Two probiotic types: A, multi-species (Bacillus sp., Pedicoccus sp., Enterococcus sp., Lactobacillus sp.) and B, mono-species (Pediococcus acidilactici) were tested at two levels each (A(1): 1.5 g kg(-1), 8.6 x 10(5) CFU g(-1); A(2): 3 g kg(-1), 1.6 x 10(6) CFU g(-1); B-1: 0.1 g kg(-1), 2.6 x 10(4) CFU g(-1); B-2: 0.2 g kg(-1), 7.2 x 10(4) CFU g(-1)) versus an unsupplemented diet (C). Diets were distributed to sextuplicate tanks, three times a day to visual satiation for 8 weeks. Growth performance and immune responses (plasma lysozyme, ACH50, peroxidase and head kidney respiratory burst) were determined at 4 and 8 weeks of feeding. Body composition and intestine morphology were determined at the end of the feeding trial. At 8 weeks, the lower dose of multi-species probiotic (A(1)) improved growth rate, while both probiotic types improved feed conversion rate compared to the control animals, at the lower dose of multi-species (A(1)) and at the higher dose of mono-species (B-2) probiotics. Body composition did not vary between treatments. At 4 weeks, ACH50 activity was significantly higher in fish fed higher dose of B probiotic (B-2, 123.7 +/- 50.6 vs 44.1 +/- 7.7 U.ml(-1) in control). At 8 weeks, lysozyxne activity was higher in fish fed A(1) (13.1 +/- 5.2 mu g ml(-1)) diet compared to fish fed control diet (7.8 +/- 1 mu g ml(-1)). Plasma peroxidase and head-kidney respiratory burst did not differ among the dietary treatments. Villi length and integrity and goblet cell counting of a cross section of the anterior intestine were not significantly different between groups. Results suggest benefits in zootechnical performance and immune humoral responses using both probiotic types, in a dose dependent manner, without apparent alterations in intestinal morphology. (C) 2015 Elsevier Ltd. All rights reserved.